نتایج جستجو برای: carbapenem

تعداد نتایج: 5710  

Journal: :Diagnostic microbiology and infectious disease 2017
Sergio García-Fernández Marta Hernández-García Aránzazu Valverde Patricia Ruiz-Garbajosa María Isabel Morosini Rafael Cantón

Performance of the CHROMagar mSuperCARBA media was assessed in both well-characterized carbapenem-resistant Enterobacteriaceae (n=52) and routine surveillance rectal swab specimens (n=211). Limit of detection ranged between 101 and 102CFU/mL except for OXA-48 producers with low-carbapenem MICs (106CFU/mL). High sensitivity (100%) and specificity (100%) were obtained with rectal swabs.

Journal: :Jurnal Teknologi Laboratorium 2022

Carbapenem-resistant Acinetobacter baumannii (CRAB) is a gram-negative bacillus that commonly causes nosocomial infection found in Indonesia. CRAB caused by resistant to Carbapenem. Resistance occurred because bacteria cause infections easily treated with antibiotics become difficult treat due the uncontrolled use of antibiotics. A. has been against carbapenem class antibiotics; and therefore, ...

2016
Tat Ming Ng Wendy X Khong Patrick N A Harris Partha P De Angela Chow Paul A Tambyah David C Lye

Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae are a common cause of bacteraemia in endemic countries and may be associated with high mortality; carbapenems are considered the drug of choice. Limited data suggest piperacillin-tazobactam could be equally effective. We aimed to compare 30-day mortality of patients treated empirically with piperacillin-tazobactam versus a car...

2014
Young Kyung Yoon Kyung Sook Yang Seung Eun Lee Hyun Jeong Kim Jang Wook Sohn Min Ja Kim

OBJECTIVE Antimicrobial stewardship programs have been proposed for reducing bacterial resistance in the hospital environment. The purpose of this study was to investigate the impact of a carbapenem-use stewardship program on the susceptibility of Acinetobacter baumannii to Group 2 carbapenems. METHODS A before and after intervention study was conducted at a university hospital from September...

Journal: :Transplant Infectious Disease 2021

Background Whether active therapy with ?-lactam/?-lactamase inhibitors (BLBLI) is as affective carbapenems for extended-spectrum ?-lactamase-producing Enterobacterales (ESBL-E) bloodstream infection (BSI) secondary to urinary tract (UTI) in kidney transplant recipients (KTRs) remains unclear. Methods We retrospectively evaluated 306 KTR admitted 30 centers from January 2014 October 2016. Therap...

Journal: :Microbiology 1998
A R Cox N R Thomson B Bycroft G S Stewart P Williams G P Salmond

Strain ATCC 39006 of Serratia marcescens makes the same carbapenem, (5R)-carbapen-2-em-3-carboxylic acid (Car), as the Erwinia carotovora strain GS101. Unlike E. carotovora, where the onset of production occurs in the late-exponential phase of growth in response to the accumulation of the small diffusible pheromone N-(3-oxohexanoyl)-L-homoserine lactone (OHHL), in S. marcescens carbapenem is pr...

Journal: :The Japanese journal of antibiotics 2012
Yukihiro Hamada Hiroshi Imaizumi Shirou Miyazawa Mitsuhiro Kida Kazui Souma Wasaburou Koizumi Keisuke Sunakawa Masakazu Kuroyama

The effectiveness of continuous regional arterial infusion therapy using protease inhibitors and antibiotics for severe acute pancreatitis has been previously reported. Carbapenem antibiotics, which have a broad antibacterial spectrum, and nafamostat mesilate are often used for this therapeutic approach. We investigated the compatibility of various carbapenem antibiotics with nafamostat mesilat...

Journal: :The new microbiologica 2014
Silvia Corbellini Francesca Caccuri Marina Gelmi Maria Antonia De Francesco Simona Fiorentini Arnaldo Caruso Cinzia Giagulli

Carbapenem-resistant K. pneumoniae has recently been reported as a new multidrug-resistant nosocomial pathogen. This study reports the emergence of carbapenem-resistant K. pneumoniae strains in Brescia Civic Hospital, Italy. Different samples, collected from April 2012 to February 2013, showed that 29 patients presented infections from multidrug-resistant K. pneumoniae and three of these patien...

2015
O. Oikonomou S. Sarrou C. C. Papagiannitsis S. Georgiadou K. Mantzarlis E. Zakynthinos G. N. Dalekos E. Petinaki

BACKGROUND Colistin-resistant/carbapenem-resistant Acinetobacter baumannii is a significant challenge for antibiotic treatment and infection control policies. Since 2012, in Central Greece an increase of colistin/pan- resistant A. baumannii has occurred, indicating the need for further analysis. METHODS A total of 86 colistin-resistant/carbapenem-resistant out of 1228 A. baumannii clinical is...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید